Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
RESEARCH TOOLSreports
Total Valuation
NeuroOne Medical Technologies has a market cap or net worth of $25.37M. The enterprise value is $28.42M.
Market Cap$25.37M
Enterprise Value$28.42M
Share Statistics
NeuroOne Medical Technologies has 47,385,525 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,385,525
Owned by Insiders11.67%
Owned by Institutions0.14%
Financial Efficiency
NeuroOne Medical Technologies’s return on equity (ROE) is -14.99 and return on invested capital (ROIC) is -368.88%.
Return on Equity (ROE)-14.99
Return on Assets (ROA)-2.29
Return on Invested Capital (ROIC)-368.88%
Return on Capital Employed (ROCE)-3.77
Revenue Per Employee203.12K
Profits Per Employee-724.59K
Employee Count17
Asset Turnover0.64
Inventory Turnover0.90
Valuation Ratios
The current PE Ratio of NeuroOne Medical Technologies is -2.15. NeuroOne Medical Technologies’s PEG ratio is 0.07.
PE Ratio-2.15
PS Ratio5.53
PB Ratio32.23
Price to Fair Value32.23
Price to FCF-2.38
Price to Operating Cash Flow-2.41
PEG Ratio0.07
Income Statement
In the last 12 months, NeuroOne Medical Technologies had revenue of 3.45M and earned -12.32M in profits. Earnings per share was -0.46.
Revenue3.45M
Gross Profit1.08M
Operating Income-11.89M
Pretax Income-12.32M
Net Income-12.32M
EBITDA-11.84M
Earnings Per Share (EPS)-0.46
Cash Flow
In the last 12 months, operating cash flow was -6.99M and capital expenditures -107.48K, giving a free cash flow of -7.10M billion.
Operating Cash Flow-6.99M
Free Cash Flow-7.10M
Free Cash Flow per Share-0.15
Dividends & Yields
NeuroOne Medical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.41
52-Week Price Change-46.90%
50-Day Moving Average0.88
200-Day Moving Average0.88
Relative Strength Index (RSI)41.24
Average Volume (3m)326.41K
Important Dates
NeuroOne Medical Technologies upcoming earnings date is May 8, 2025, TBA Not Confirmed.
Last Earnings DateFeb 12, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
NeuroOne Medical Technologies as a current ratio of 2.09, with Debt / Equity ratio of 8.09%
Current Ratio2.09
Quick Ratio0.90
Debt to Market Cap<0.01
Net Debt to EBITDA0.10
Interest Coverage Ratio-51.91
Taxes
In the past 12 months, NeuroOne Medical Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NeuroOne Medical Technologies EV to EBITDA ratio is -2.14, with an EV/FCF ratio of -2.27.
EV to Sales7.33
EV to EBITDA-2.14
EV to Free Cash Flow-2.27
EV to Operating Cash Flow-2.30
Balance Sheet
NeuroOne Medical Technologies has $1.13M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$896.97K billion.
Cash & Marketable Securities$1.13M
Total Debt$0.00
Net Cash-$896.97K
Net Cash Per Share-$0.02
Tangible Book Value Per Share$0.03
Margins
Gross margin is 47.66%, with operating margin of -344.26%, and net profit margin of -356.74%.
Gross Margin47.66%
Operating Margin-344.26%
Pretax Margin-356.74%
Net Profit Margin-356.74%
EBITDA Margin-342.96%
EBIT Margin-350.10%
Analyst Forecast
The average price target for NeuroOne Medical Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast210.76%
EPS Growth Forecast61.22%